Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
for Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD
Drug: Ixo-vec
Sites in West Columbia +11 more locations
Sponsor: Adverum Biotechnologies, Inc.
Sex: All·Age: 50+
Code: NCT07630649·Phase 2·Recruiting·Listed Jun 2026